New Virus Variant Detection Based on the Optimal Natural Metric
Author:
Yu Hongyu1ORCID, Yau Stephen12ORCID
Affiliation:
1. Department of Mathematical Sciences, Tsinghua University, Beijing 100084, China 2. Beijing Institute of Mathematical Sciences and Applications (Bimsa), Beijing 101408, China
Abstract
The highly variable SARS-CoV-2 virus responsible for the COVID-19 pandemic frequently undergoes mutations, leading to the emergence of new variants that present novel threats to public health. The determination of these variants often relies on manual definition based on local sequence characteristics, resulting in delays in their detection relative to their actual emergence. In this study, we propose an algorithm for the automatic identification of novel variants. By leveraging the optimal natural metric for viruses based on an alignment-free perspective to measure distances between sequences, we devise a hypothesis testing framework to determine whether a given viral sequence belongs to a novel variant. Our method demonstrates high accuracy, achieving nearly 100% precision in identifying new variants of SARS-CoV-2 and HIV-1 as well as in detecting novel genera in Orthocoronavirinae. This approach holds promise for timely surveillance and management of emerging viral threats in the field of public health.
Funder
National Natural Science Foundation of China Tsinghua University Education Foundation fund
Reference32 articles.
1. LaTourrette, K., and Garcia-Ruiz, H. (2022). Determinants of Virus Variation, Evolution, and Host Adaptation. Pathogens, 11. 2. Uddin, M., Mustafa, F., Rizvi, T.A., Loney, T., Al Suwaidi, H., Al-Marzouqi, A.H.H., Kamal Eldin, A., Alsabeeha, N., Adrian, T.E., and Stefanini, C. (2020). SARS-CoV-2/COVID-19: Viral Genomics, Epidemiology, Vaccines, and Therapeutic Interventions. Viruses, 12. 3. HIV infection: Epidemiology, pathogenesis, treatment, and prevention;Maartens;Lancet,2014 4. Vulturar, D.-M., Moacă, L.-Ș., Neag, M.A., Mitre, A.-O., Alexescu, T.-G., Gherman, D., Făgărășan, I., Chețan, I.M., Gherman, C.D., and Melinte, O.-E. (2024). Delta Variant in the COVID-19 Pandemic: A Comparative Study on Clinical Outcomes Based on Vaccination Status. J. Pers. Med., 14. 5. Structural and functional properties of SARS-CoV-2 spike protein: Potential antivirus drug development for COVID-19;Huang;Acta Pharmacol. Sin.,2020
|
|